BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-455-5p (miR-455-5p); adenosine deaminase RNA-specific (ADAR; ADAR1)

March 19, 2015 7:00 AM UTC

Cell culture and mouse studies suggest inhibiting wild-type miR-455-5p or stimulating ADAR1 activity could help prevent metastatic melanoma. In normal cells, the RNA-editing enzyme ADAR1 converts aden...